Mouse Sh3rf2/2310046K19/9130023G24Rik ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_001146299.1)

Cat. No.: vGMAAV001363

Pre-made Mouse Sh3rf2/2310046K19/9130023G24Rik Adeno-associated virus particle for Sh3rf2 in-vivo study, mechanism of action (MOA) research and Sh3rf2-associated gene therapy development.

At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.

Product information

Catalog No. Product Name AAV serotype AAV Grade AAV quantity
vGMAAV001363 Mouse Sh3rf2 Adeno-associate virus(AAV) particle AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF Pilot Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
Research Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAAV001363
Gene Name Sh3rf2
Accession Number NM_001146299.1
Gene ID 269016
Species Mouse
Product Type Adeno-associate virus(AAV) particle (overexpression)
Insert Length 2208 bp
Gene Alias 2310046K19,9130023G24Rik,AI452083,Ppp1r39,RNF158
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Null
Fusion Tag Null
Promoter CaMKⅡ
Resistance Amplicin
ORF Nucleotide Sequence ATGGATGATTTGACGTTACTTGATCTCCTGGAGTGCCCTGTGTGCTTTGAAAAGCTCGATGTCACAGCCAAAGTTCTCCCCTGCCAGCACACCTTCTGCAAACCATGTCTACAGAGGATTTTCAAGGCCCACAAGGAGCTGAGGTGCCCGGAATGCAGGACTCTGGTGTTCTGCAGCATCGAGGCTCTGCCAGCCAACCTGTTGCTCGTGCGTTTGCTGGATGGTGTGCGTTCCGGACAGAGCTCGTGGAAAGGAGGCTCCTTCCGAAGGCCTCGGATACTGACCTTGCAGGACAACAGGAAAGCCAAGAGCAGCCCCAGAAGTCTACAGGCTAGCCCTTTCCGGCTGGTGCCCAGTGTCAGGATCCACATGGATGGGGTGCCTCGAGCCAAGGCCTTGTGCAACTACAGAGGGAAGAATCCTGGCGACCTGAAGTTTAATAAAGGCGATGTCATCCTCCTTCGGAGACAGCTTGATGAGAACTGGTACCAGGGGGAGATTAATGGCGTCAGCGGGATCTTCCCGGCCAGCTCTGTGGAAGTCATCAAACAGCTGCCCCAACCACCCCCACTCTGCAGAGCCCTCTACAACTTTGACCTTCGAGACAAGGATAAGAGTGAGAACCAGGACTGCCTGACCTTCCTCAAGGATGATGTCATCACAGTGATCAGCCGTGTAGATGAGAACTGGGCAGAGGGAAAGCTCGGAGATAAAGTGGGCATCTTCCCCATCTTGTTTGTAGAGCCAAACGTCTCGGCAAGACACCTCCTAGAGAACAAAGGACATCAGTTATCACGCACAAGACACCTGTCCCTGATGTCCTCCCCATCCAGAGGCAAAGCGACCAACACATCCTCGCTCCGAAAGAGCCCAGGGTCCAGGAGGAAGGGATCTGGGCAGTTCTCCATGACTACAGCTTTGAACACACTCAACCGTACAGTCCATTCTCCTGAAGGCCACCAGATGGTGGAAATCAGCACCCCGATGCTCATCAGCTCTAACAGCCCCTCTGTGCTCACCCAACATGGGGACAAGGCAGACTTCCCTACCAGCTCTACAGGACAGGTCAGCAGTTCTCAGCCTGCACCTGCCTCCCCGGGACATTCCACAGCCATGGTCAGTGTGCCCAGCTCCCAGCAACACCTTTCAAATAACATGTTTGTAGCCCTACACACTTACTCAGCCCATAGACCCGAAGAGCTGGACCTGCAGAAGGGAGAAGGCATCAGGGTTCTGGGCAAGTACCAGGATGGCTGGCTGAAGGGCCTCTCCTTACTCACTGGACGAACTGGCATCTTTCCAAGCGACTATGTCATCCCAGTCTTCAGTTCAACAGCTAGAAAGACATCTAGTTTTCCTGATTCCCGGAGCCCCACTGTCTGCACCACATGGGCGTTATCCACCTCCTCTGTGTCCTCCCAGGGTAGCTTTGCAGAAGGTGATCCCCGGCAAAGTGGACCCTTCAAATCTGTCTTTGTGCCCACTGCCGTAGTTAACCCTTCGAGGAGCACACCTGGCCCAGGGTCTTCTGGACAAGGGTCTCTTAGGAAAGTGCGGAGCAGCATGAGAAAAAATGGATCCCTGCAGAGACCAGTTCAATCTGGGATCCCCACTTTCATGGTGGGCTCCCTCAGGTGCAGTCCTACCATGGTGATCCGGCCTCAGAGGTTCCAGTTTTATCCGCCACAGGGGATGACCCCTTCCCCGACACCGATAATGGTGGAGATGGGGTCTAAATCTATTTACACTGGGGAGCCTGCCCTGACCTGCATCAACAGAGGTAGCAAGACCAGGATCCACTCAGCAGGCAATTCCATCATCATGGAAGGCAAAGAAACGCCCATCAAGAGTGAACCGCCACCCAAGCCGCCTGCATCTGCGCCACCCTCCATCCTCGTGAAACCAGAAAATTCAAAGAATGGCACTGAAAAGCAAGTCAAAACCGTGAGATTTCAGAATTACAGCCCTCCGCCCACCAAACACTCTGCCTCCAGTCCCACCTCTGGAAAGCACGACCATCCAGCCACCTTGAAGGGGTCCCAGCATGAAGCAGTCTCCTCGGGAGGAGAGATGACCATTCTATTTGCCCACCGAAGTGGCTGCCACTCCGGGCAACAAACAGACCTTCGGAGAAAGTCAGCCTTTGGCAAGACCATGCCCTTATTGTCCACTGCTTCAGCCACACAGACCTTGTTTCCCAGCAAATGA
ORF Protein Sequence MDDLTLLDLLECPVCFEKLDVTAKVLPCQHTFCKPCLQRIFKAHKELRCPECRTLVFCSIEALPANLLLVRLLDGVRSGQSSWKGGSFRRPRILTLQDNRKAKSSPRSLQASPFRLVPSVRIHMDGVPRAKALCNYRGKNPGDLKFNKGDVILLRRQLDENWYQGEINGVSGIFPASSVEVIKQLPQPPPLCRALYNFDLRDKDKSENQDCLTFLKDDVITVISRVDENWAEGKLGDKVGIFPILFVEPNVSARHLLENKGHQLSRTRHLSLMSSPSRGKATNTSSLRKSPGSRRKGSGQFSMTTALNTLNRTVHSPEGHQMVEISTPMLISSNSPSVLTQHGDKADFPTSSTGQVSSSQPAPASPGHSTAMVSVPSSQQHLSNNMFVALHTYSAHRPEELDLQKGEGIRVLGKYQDGWLKGLSLLTGRTGIFPSDYVIPVFSSTARKTSSFPDSRSPTVCTTWALSTSSVSSQGSFAEGDPRQSGPFKSVFVPTAVVNPSRSTPGPGSSGQGSLRKVRSSMRKNGSLQRPVQSGIPTFMVGSLRCSPTMVIRPQRFQFYPPQGMTPSPTPIMVEMGSKSIYTGEPALTCINRGSKTRIHSAGNSIIMEGKETPIKSEPPPKPPASAPPSILVKPENSKNGTEKQVKTVRFQNYSPPPTKHSASSPTSGKHDHPATLKGSQHEAVSSGGEMTILFAHRSGCHSGQQTDLRRKSAFGKTMPLLSTASATQTLFPSK

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector pGMAAV001363 Mouse Sh3rf2 Adeno-associate virus(AAV) plasmid




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.